Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Orbassano – page 6

213 clinical trials in Orbassano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Orbassano at a glance
213
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

213 trials in Orbassano

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Belimumab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fondazione Ricerca Traslazionale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:AstraZeneca AB

Osteoarthritis

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Clodronate Disodium
  • Sponsor:Spa Societa Prodotti Antibiotici S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:OSE Immunotherapeutics
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Stx-241
  • Sponsor:Pierre Fabre Medicament
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fondazione Toscana Gabriele Monasterio

Myelofibrosis

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Orbassano

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on lung cancer and mesothelioma treatments, including studies of novel therapeutic combinations and targeted therapies.

  • Non-Small Cell Lung Cancer (NSCLC) Studies
  • Pleural Mesothelioma Treatments
  • Renal Cell Carcinoma Research

Multiple trials evaluating immunotherapy approaches and targeted molecular treatments for advanced stages of cancer.

02 Hematological Disorders

Research initiatives investigating treatments for blood disorders and related conditions, with particular focus on innovative therapies.

  • Sickle Cell Disease Management
  • Acute Myeloid Leukemia Treatments
  • Lymphoblastic Leukemia Studies

Studies examining new therapeutic approaches for blood disorders and their complications.

03 Cardiovascular Research

Clinical investigations focusing on heart failure prevention and innovative cardiovascular treatments.

  • Heart Failure Prevention Studies
  • Cardiovascular Risk Management
  • Novel Drug Combinations

Trials evaluating new therapeutic approaches for reducing cardiovascular events and improving patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.